Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Arvida Group Limited Director's Dealing 2018

Aug 5, 2018

66157_rns_2018-08-06_0a2126e4-506c-4c26-8574-5fee0d96292b.pdf

Director's Dealing

Open in viewer

Opens in your device viewer

==> picture [105 x 29] intentionally omitted <==

Ongoing Disclosure Notice

Disclosure of Directors and Senior Managers Relevant Interests

Sections 297(2) and 298(2), Financial Markets Conduct Act 2013

To NZX Limited; and
Name of listed issuer: Arvida GroupLimited
Date this disclosure made: 6-Aug-18
Date of last disclosure: 18-Jun-18
Director or senior manager giving disclosure
Full name(s): Peter David Wilson
Name of listed issuer: Arvida GroupLimited
Name of related body corporate (if applicable): n/a
Position held in listed issuer: Director
Summary of acquisition or disposal of relevant interest (excluding specified derivatives)
Class of affected quoted financial products: OrdinaryShares(ARV)
Registered holder and beneficial owner for
Peter David Wilson
Nature of the affected relevant interest(s):
Related party and non-beneficial owner for
the PD Wilson FamilyTrust
For that relevant interest-
Peter David Wilson (432,383)
Number held in class before acquisition or disposal: Mary Clare Wilson & Anthony Frederick
Wilson as trustees of the PD Wilson Family
Trust(36,015)
Peter David Wilson (453,398)
Number held in class after acquisition or disposal: Mary Clare Wilson & Anthony Frederick
Wilson as trustees of the PD Wilson Family
Trust(15,000)
Peter David Wilson (453,398)
Current registered holder(s): Mary Clare Wilson & Anthony Frederick
Wilson as trustees of the PD Wilson Family
Trust(15,000)
Registered holder(s) once transfers are registered: n/a
Summary of acquisition or disposal of specified derivatives relevant interest (if applicable)
Type of affected derivative: n/a
Class of underlying financial products: n/a
Details of affected derivative-
The notional value of the derivative (if any) or the notional amount of underlying financial
products (if any): n/a
A statement as to whether the derivative is cash settled or physically settled: n/a
Maturity date of the derivative (if any): n/a
Expiry date of the derivative(if any): n/a
The price specified in the terms of the derivative (if any): n/a
Any other details needed to understand how the amount of the consideration payable
under the derivative or the value of the derivative is affected by the value of the
underlying financial products: n/a
For that derivative,-
Parties to the derivative: n/a
If the director or senior manager is not a party to the derivative, the nature of the relevant
interest in the derivative: n/a
Details of transactions giving rise to acquisition or disposal
Total number of transactions to which notice relates: One
Details of transactions requiring disclosure-
Date of transaction:
Nature of transaction:
Name of anyotherpartyorparties to the transaction(if known):
The consideration, expressed in New Zealand dollars, paid or received for the acquisition
or disposal. If the consideration was not in cash and cannot be readily by converted into
a cash value,describe the consideration:
Number of financialproducts to which the transaction related:
If the issuer has a financial products trading policy that prohibits directors or senior
managers from trading during any period without written clearance (a closed period)
include the following details—
Whether relevant interests were acquired or disposed of duringa closedperiod:
Details of transactions requiring disclosure-
Date of transaction:
Nature of transaction:
Name of anyotherpartyorparties to the transaction(if known):
The consideration, expressed in New Zealand dollars, paid or received for the acquisition
or disposal. If the consideration was not in cash and cannot be readily by converted into
a cash value,describe the consideration:
Number of financialproducts to which the transaction related:
If the issuer has a financial products trading policy that prohibits directors or senior
managers from trading during any period without written clearance (a closed period)
include the following details—
Whether relevant interests were acquired or disposed of duringa closedperiod:
3-Aug-18
Transfer of ordinary shares between holders
at marketprice
n/a
$27,320
21,015 OrdinaryShares
No
n/a
n/a
n/a
n/a
n/a
n/a
n/a
3-Aug-18
Transfer of ordinary shares between holders
at marketprice
n/a
$27,320
21,015 OrdinaryShares
No
n/a
n/a
n/a
n/a
n/a
n/a
n/a
Whether relevant interests were acquired or disposed of duringa closedperiod: No
Whether prior written clearance was provided to allow the acquisition or disposal to
proceed during the closed period:
n/a
Date of the prior written clearance (if any): n/a
Summary of other relevant interests after acquisition or disposal:
Class ofquoted financialproducts:
Nature of relevant interest:
For that relevant interest,-
Number held in class:
Current registered holder(s):
For a derivative relevant interest,-
Type of derivative:
Details of derivative,-
n/a
n/a
n/a
The notional value of the derivative (if any) or the notional amount of underlying financial
products (if any):
n/a
A statement as to whether the derivative is cash settled or physically settled: n/a
Maturity date of the derivative (if any): n/a
Expiry date of the derivative (if any): n/a
The price's specified terms (if any): n/a
Any other details needed to understand how the amount of the consideration payable
under the derivative or the value of the derivative is affected by the value of the
underlying financial products:
n/a
For that derivative relevant interest,- n/a
Parties to the derivative: n/a
If the director or senior manager is not a party to the derivative, the nature of the relevant
interest in the derivative:
n/a

Certification

Certification
I certify that, to the best of my knowledge and belief, the information contained in this
disclosure is correct and that I am duly authorised to make this disclosure by all persons
for whom it is made.
Signature of director or officer: n/a
Date of signature: n/a
or
Signature of person authorised to sign on behalf of director or officer:
Date of signature: 6-Aug-18
Name and title of authorised person: Jeremy Nicoll, CFO